vTv Therapeutics VTVT
NASDAQ VTVT
$33.35 -0.12 (-0.36%)
At close: Sep 4, 2026 · 4:00 PM EDT

vTv Therapeutics (VTVT) Other Non-Current Assets (2014 - 2026)

vTv Therapeutics' (VTVT) quarterly Other Non-Current Assets came in at $4000.0 in Q2 2026, down 20.0% quarter-over-quarter from $5000.0 in Q1 2026.

Analysis

vTv Therapeutics (VTVT) Other Non-Current Assets (2014 - 2026) Analysis & Trends

vTv Therapeutics has disclosed Other Non-Current Assets across 10 years of filings, most recently posting $4000.0 for Q2 2026.

  • In Q2 2026, Other Non-Current Assets changed N/A year-over-year to $4000.0; the TTM figure through Jun 2026 stood at $4000.0 (changed N/A YoY), while the FY2025 annual figure was $6000.0, down 96.08% from the prior year.
  • Other Non-Current Assets came in at $4000.0 for Q2 2026 at vTv Therapeutics, down from $5000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $153000.0 in Q4 2024 to a low of $4000.0 in Q2 2026.
  • Average Other Non-Current Assets over 3 years is $42000.0, with a median of $5500.0 recorded in 2025.
  • The largest YoY upside for Other Non-Current Assets was 96.08% in 2025 against a maximum downside of 96.08% in 2025.
  • Over 3 years, Other Non-Current Assets stood at $153000.0 in 2024, then sank by 96.08% to $6000.0 in 2025, then slumped by 33.33% to $4000.0 in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Assets figures were $4000.0 in Q2 2026, $5000.0 in Q1 2026, and $6000.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn 14.27 Bn
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn 10.73 Bn
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn 5.93 Bn
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn 9.94 Bn
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn 5.50 Bn
7 Revolution Medicines 45.00 Bn 45.00 Bn - 42.45 Mn
8 BeOne Medicines 40.49 Bn 35.39 Bn 1.53 Bn 109.58 Mn
9 Incyte 25.47 Bn 20.94 Bn 1.57 Bn 86.76 Mn
10 vTv Therapeutics 413.85 Mn 413.85 Mn - 4,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4,000.00
Mar 31, 2026 5,000.00
Dec 31, 2025 6,000.00
Dec 31, 2024 153,000.00
Jun 30, 2020 444,000.00
Mar 31, 2020 2.50 Mn
Dec 31, 2019 2.50 Mn
Sep 30, 2019 2.50 Mn
Jun 30, 2019 2.50 Mn
Mar 31, 2019 2.50 Mn
Dec 31, 2018 2.50 Mn
Sep 30, 2018 2.50 Mn
Jun 30, 2018 2.50 Mn
Mar 31, 2018 2.50 Mn
Dec 31, 2017 2.50 Mn
Sep 30, 2017 2.25 Mn
Jun 30, 2017 2.25 Mn
Mar 31, 2017 1.97 Mn
Dec 31, 2016 1.93 Mn
Sep 30, 2016 2.10 Mn